Seven Passive 1-h Hypoxia Exposures Do Not Prevent AMS in Susceptible Individuals

Martin Faulhaber, Elena Pocecco, Hannes Gatterer, Martin Niedermeier, Maike Huth, Tobias Dünnwald, Verena Menz, Luciano Bernardi, Martin Burtscher

Research output: Contribution to journalArticle

Abstract

PURPOSE: The present study evaluated the effects of a pre-acclimatization program comprising 7 passive 1-hour exposures to 4,500 m normobaric hypoxia on the prevalence and severity of acute mountain sickness (AMS) during a subsequent exposure to real high altitude in persons susceptible to AMS. METHODS: The project was designed as a randomized controlled trial including 32 healthy female and male participants with known susceptibility to AMS symptoms. After baseline measurements participants were randomly assigned to the hypoxia or the control group to receive the pre-acclimatization program (7 passive 1-hour exposures within 7 days to normobaric hypoxia or sham hypoxia). After completing pre-acclimatization, participants were transported (bus, cog railway) to real high altitude (Mönchsjoch hut, Switzerland, 3,650 m) and stayed there for 45 hours (2 nights). Symptoms of AMS and physiological responses were determined repeatedly. RESULTS: AMS incidence and severity did not significantly differ between groups during the high-altitude exposure. In total, 59 % of the hypoxia and 67 % of the control group suffered from AMS at one or more time points during the high-altitude exposure. Hypoxic and hypercapnic ventilatory responses were not affected by the pre-acclimatization program. Resting ventilation at high altitude tended to be higher (P = 0.06) in the hypoxia group compared to the control group. No significant between-group differences were detected for heart rate variability, arterial oxygen saturation, hematological and ventilatory parameters during the high altitude exposure. CONCLUSION: Pre-acclimatization using 7 passive 1-hour exposures to normobaric hypoxia corresponding to 4,500 m did not prevent AMS development during a subsequent high-altitude exposure in AMS-susceptible persons.

Original languageEnglish
JournalMedicine and Science in Sports and Exercise
DOIs
Publication statusAccepted/In press - Jul 12 2016

Fingerprint

Altitude Sickness
Acclimatization
Control Groups
Hypoxia
Motor Vehicles
Switzerland
Ventilation
Randomized Controlled Trials
Heart Rate
Oxygen

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Faulhaber, M., Pocecco, E., Gatterer, H., Niedermeier, M., Huth, M., Dünnwald, T., ... Burtscher, M. (Accepted/In press). Seven Passive 1-h Hypoxia Exposures Do Not Prevent AMS in Susceptible Individuals. Medicine and Science in Sports and Exercise. https://doi.org/10.1249/MSS.0000000000001036

Seven Passive 1-h Hypoxia Exposures Do Not Prevent AMS in Susceptible Individuals. / Faulhaber, Martin; Pocecco, Elena; Gatterer, Hannes; Niedermeier, Martin; Huth, Maike; Dünnwald, Tobias; Menz, Verena; Bernardi, Luciano; Burtscher, Martin.

In: Medicine and Science in Sports and Exercise, 12.07.2016.

Research output: Contribution to journalArticle

Faulhaber, M, Pocecco, E, Gatterer, H, Niedermeier, M, Huth, M, Dünnwald, T, Menz, V, Bernardi, L & Burtscher, M 2016, 'Seven Passive 1-h Hypoxia Exposures Do Not Prevent AMS in Susceptible Individuals', Medicine and Science in Sports and Exercise. https://doi.org/10.1249/MSS.0000000000001036
Faulhaber, Martin ; Pocecco, Elena ; Gatterer, Hannes ; Niedermeier, Martin ; Huth, Maike ; Dünnwald, Tobias ; Menz, Verena ; Bernardi, Luciano ; Burtscher, Martin. / Seven Passive 1-h Hypoxia Exposures Do Not Prevent AMS in Susceptible Individuals. In: Medicine and Science in Sports and Exercise. 2016.
@article{f9e27950870d458c994fe9b7634b2219,
title = "Seven Passive 1-h Hypoxia Exposures Do Not Prevent AMS in Susceptible Individuals",
abstract = "PURPOSE: The present study evaluated the effects of a pre-acclimatization program comprising 7 passive 1-hour exposures to 4,500 m normobaric hypoxia on the prevalence and severity of acute mountain sickness (AMS) during a subsequent exposure to real high altitude in persons susceptible to AMS. METHODS: The project was designed as a randomized controlled trial including 32 healthy female and male participants with known susceptibility to AMS symptoms. After baseline measurements participants were randomly assigned to the hypoxia or the control group to receive the pre-acclimatization program (7 passive 1-hour exposures within 7 days to normobaric hypoxia or sham hypoxia). After completing pre-acclimatization, participants were transported (bus, cog railway) to real high altitude (M{\"o}nchsjoch hut, Switzerland, 3,650 m) and stayed there for 45 hours (2 nights). Symptoms of AMS and physiological responses were determined repeatedly. RESULTS: AMS incidence and severity did not significantly differ between groups during the high-altitude exposure. In total, 59 {\%} of the hypoxia and 67 {\%} of the control group suffered from AMS at one or more time points during the high-altitude exposure. Hypoxic and hypercapnic ventilatory responses were not affected by the pre-acclimatization program. Resting ventilation at high altitude tended to be higher (P = 0.06) in the hypoxia group compared to the control group. No significant between-group differences were detected for heart rate variability, arterial oxygen saturation, hematological and ventilatory parameters during the high altitude exposure. CONCLUSION: Pre-acclimatization using 7 passive 1-hour exposures to normobaric hypoxia corresponding to 4,500 m did not prevent AMS development during a subsequent high-altitude exposure in AMS-susceptible persons.",
author = "Martin Faulhaber and Elena Pocecco and Hannes Gatterer and Martin Niedermeier and Maike Huth and Tobias D{\"u}nnwald and Verena Menz and Luciano Bernardi and Martin Burtscher",
year = "2016",
month = "7",
day = "12",
doi = "10.1249/MSS.0000000000001036",
language = "English",
journal = "Medicine and Science in Sports and Exercise",
issn = "0195-9131",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Seven Passive 1-h Hypoxia Exposures Do Not Prevent AMS in Susceptible Individuals

AU - Faulhaber, Martin

AU - Pocecco, Elena

AU - Gatterer, Hannes

AU - Niedermeier, Martin

AU - Huth, Maike

AU - Dünnwald, Tobias

AU - Menz, Verena

AU - Bernardi, Luciano

AU - Burtscher, Martin

PY - 2016/7/12

Y1 - 2016/7/12

N2 - PURPOSE: The present study evaluated the effects of a pre-acclimatization program comprising 7 passive 1-hour exposures to 4,500 m normobaric hypoxia on the prevalence and severity of acute mountain sickness (AMS) during a subsequent exposure to real high altitude in persons susceptible to AMS. METHODS: The project was designed as a randomized controlled trial including 32 healthy female and male participants with known susceptibility to AMS symptoms. After baseline measurements participants were randomly assigned to the hypoxia or the control group to receive the pre-acclimatization program (7 passive 1-hour exposures within 7 days to normobaric hypoxia or sham hypoxia). After completing pre-acclimatization, participants were transported (bus, cog railway) to real high altitude (Mönchsjoch hut, Switzerland, 3,650 m) and stayed there for 45 hours (2 nights). Symptoms of AMS and physiological responses were determined repeatedly. RESULTS: AMS incidence and severity did not significantly differ between groups during the high-altitude exposure. In total, 59 % of the hypoxia and 67 % of the control group suffered from AMS at one or more time points during the high-altitude exposure. Hypoxic and hypercapnic ventilatory responses were not affected by the pre-acclimatization program. Resting ventilation at high altitude tended to be higher (P = 0.06) in the hypoxia group compared to the control group. No significant between-group differences were detected for heart rate variability, arterial oxygen saturation, hematological and ventilatory parameters during the high altitude exposure. CONCLUSION: Pre-acclimatization using 7 passive 1-hour exposures to normobaric hypoxia corresponding to 4,500 m did not prevent AMS development during a subsequent high-altitude exposure in AMS-susceptible persons.

AB - PURPOSE: The present study evaluated the effects of a pre-acclimatization program comprising 7 passive 1-hour exposures to 4,500 m normobaric hypoxia on the prevalence and severity of acute mountain sickness (AMS) during a subsequent exposure to real high altitude in persons susceptible to AMS. METHODS: The project was designed as a randomized controlled trial including 32 healthy female and male participants with known susceptibility to AMS symptoms. After baseline measurements participants were randomly assigned to the hypoxia or the control group to receive the pre-acclimatization program (7 passive 1-hour exposures within 7 days to normobaric hypoxia or sham hypoxia). After completing pre-acclimatization, participants were transported (bus, cog railway) to real high altitude (Mönchsjoch hut, Switzerland, 3,650 m) and stayed there for 45 hours (2 nights). Symptoms of AMS and physiological responses were determined repeatedly. RESULTS: AMS incidence and severity did not significantly differ between groups during the high-altitude exposure. In total, 59 % of the hypoxia and 67 % of the control group suffered from AMS at one or more time points during the high-altitude exposure. Hypoxic and hypercapnic ventilatory responses were not affected by the pre-acclimatization program. Resting ventilation at high altitude tended to be higher (P = 0.06) in the hypoxia group compared to the control group. No significant between-group differences were detected for heart rate variability, arterial oxygen saturation, hematological and ventilatory parameters during the high altitude exposure. CONCLUSION: Pre-acclimatization using 7 passive 1-hour exposures to normobaric hypoxia corresponding to 4,500 m did not prevent AMS development during a subsequent high-altitude exposure in AMS-susceptible persons.

UR - http://www.scopus.com/inward/record.url?scp=84978512617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978512617&partnerID=8YFLogxK

U2 - 10.1249/MSS.0000000000001036

DO - 10.1249/MSS.0000000000001036

M3 - Article

AN - SCOPUS:84978512617

JO - Medicine and Science in Sports and Exercise

JF - Medicine and Science in Sports and Exercise

SN - 0195-9131

ER -